| Description |
The CD4+CD25+ Regulatory T Cell Isolation Kit was developed for the isolation of CD4+CD25+ cells from PBMCs. The kit contains a cocktail of biotinylated antibodies and Anti-Biotin MicroBeads for depletion of non-CD4+ T cells, and CD25 MicroBeads for subsequent positive selection of the CD4+CD25+ cells. The kit also includes CD25-PE for quality control of the separations. CD4+CD25+ T cells act as regulatory T cells upon activation through their T cell receptor. CD4+CD25+ regulatory T cells were originally discovered in mice, but a population with similar phenotypic and functional properties has also been characterized in humans. Regulatory CD4+CD25+ T cells seem to suppress harmful immunological reactions to self or foreign antigens. |
| Applications |
| The CD4+CD25+ Regulatory T Cell Isolation Kit has been used to investigate the role of CD4+CD25+ regulatory T cells in autoimmune diseases1,2, antitumor immunity3-5, allergy6, and in infectious diseases7. For further characterization, CD4+CD25+ regulatory T cells were isolated from patients suffering from rheumatoid arthritis1 or multiple sclerosis2, from acute T cell lymphoma patients4, from tumor biopsy specimens of non-Hodgkin lymphoma patients5 as well as from patients with atopic dermatitis6. |
| |
| Figure 1 |
| Isolation of human peripheral blood CD4+CD25+ regulatory T cells using the CD4+CD25+ Regulatory T Cell Isolation Kit. |
| Pre-enriched CD4+ T cells after depletion of non-CD4+ cells |
 |
| CD4+CD25+ T cells |
 |
|
| Figure 2 |
| Analysis of Foxp3 expression by CD4+CD25+ regulatory T cells, gated on CD4+ cells |
| Before separation |
 |
| After separation |
 |
|
| Figure 3 |
| Analysis of CD127 expression by CD4+CD25+ regulatory T cells, gated on CD4+ cells. |
| Before separation |
 |
| After separation |
 |
|
|